Cell Line Development Market Analysis

The global cell line development market is segmented and analyzed for demand and supply by cell type into CHO cells, BHK 21 cells, NSO cells, murine C127 cells, NIH3T3 cells, L929 cells, and others. Out of which, BHK 21 cells segment is anticipated to garner the revenue share of 12.63% by the end of 2037, by growing at a highest CAGR of 12.84% during the forecast period. Increasing cases of rabies is expected to boost the market growth. BHK 21 cells are most frequently used cells lines. They are extensively used for treating rabies. The World Organization for Animal Health use these BHK21 cells in the regular diagnosis of rabies. To thrive in serum- or animal-component-free cell medium for the manufacture of rabies vaccines, BHK21 cells appear to have already undergone the necessary adaptations. Additionally CHO cells segment is anticipated to garner the largest revenue share of USD 27.89% by the end of 2036.

Our in-depth analysis of the global cell line development market includes the following segments: